<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-13T11:47:02Z</responseDate>
  <request identifier="oai:figshare.com:article/34026327" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34026327</identifier>
        <datestamp>2026-09-29T17:29:53Z</datestamp>
        <setSpec>category_7</setSpec>
        <setSpec>category_12</setSpec>
        <setSpec>category_13</setSpec>
        <setSpec>category_14</setSpec>
        <setSpec>category_61</setSpec>
        <setSpec>category_62</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>category_122</setSpec>
        <setSpec>category_132</setSpec>
        <setSpec>portal_5</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>&lt;p&gt;Multivariate survival analysis.&lt;/p&gt;</dc:title>
          <dc:creator>Kohei Matsuoka (3692662)</dc:creator>
          <dc:creator>Yuichiro Miki (5754011)</dc:creator>
          <dc:creator>Ryota Kawai (11312898)</dc:creator>
          <dc:creator>Masaki Nishiyama (17264159)</dc:creator>
          <dc:creator>Yuki Seki (4988693)</dc:creator>
          <dc:creator>Kenji Kuroda (5754017)</dc:creator>
          <dc:creator>Hiroaki Kasashima (656226)</dc:creator>
          <dc:creator>Mami Yoshii (8307636)</dc:creator>
          <dc:creator>Tatsuro Tamura (7841207)</dc:creator>
          <dc:creator>Masatsune Shibutani (765415)</dc:creator>
          <dc:creator>Takahiro Toyokawa (765421)</dc:creator>
          <dc:creator>Ayumi Shintani (11873)</dc:creator>
          <dc:creator>Kiyoshi Maeda (765416)</dc:creator>
          <dc:subject>Medicine</dc:subject>
          <dc:subject>Cell Biology</dc:subject>
          <dc:subject>Genetics</dc:subject>
          <dc:subject>Molecular Biology</dc:subject>
          <dc:subject>Developmental Biology</dc:subject>
          <dc:subject>Marine Biology</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>Mental Health</dc:subject>
          <dc:subject>Infectious Diseases</dc:subject>
          <dc:subject>rapidly aging population</dc:subject>
          <dc:subject>optimize treatment strategies</dc:subject>
          <dc:subject>major complication group</dc:subject>
          <dc:subject>kaplan &amp;# 8211</dc:subject>
          <dc:subject>01 &amp;# 8211</dc:subject>
          <dc:subject>multivariate analysis showed</dc:subject>
          <dc:subject>meier analysis showed</dc:subject>
          <dc:subject>subgroup analysis</dc:subject>
          <dc:subject>study showed</dc:subject>
          <dc:subject>&amp;# 8220</dc:subject>
          <dc:subject>xlink "&gt;</dc:subject>
          <dc:subject>underwent gastrectomy</dc:subject>
          <dc:subject>study aimed</dc:subject>
          <dc:subject>significantly worse</dc:subject>
          <dc:subject>scale studies</dc:subject>
          <dc:subject>postoperative complications</dc:subject>
          <dc:subject>poorer os</dc:subject>
          <dc:subject>hr 2</dc:subject>
          <dc:subject>gastric cancer</dc:subject>
          <dc:subject>future large</dc:subject>
          <dc:subject>classified according</dc:subject>
          <dc:subject>ci 1</dc:subject>
          <dc:subject>baseline characteristics</dc:subject>
          <dc:subject>80 years</dc:subject>
          <dc:subject>3 %),</dc:subject>
          <dc:subject>063 ),</dc:subject>
          <dc:subject>049 ).</dc:subject>
          <dc:subject>004 ).</dc:subject>
          <dc:description>&lt;div&gt;
&lt;p&gt;Background&lt;/p&gt;&lt;p&gt;Japan’s rapidly aging population has led to an increase in elderly patients undergoing gastrectomy for gastric cancer. However, the impact of postoperative complications on survival in patients aged ≥80 years remains unclear. This study aimed to evaluate the association between postoperative complications and survival outcomes in patients aged ≥80 years with gastric cancer.&lt;/p&gt;
&lt;p&gt;Materials and methods&lt;/p&gt;&lt;p&gt;We retrospectively analyzed 61 patients aged ≥80 years who underwent gastrectomy with D2 lymph node dissection between 1999 and 2020. Postoperative complications were classified according to the Clavien-Dindo (CD) classification into a “no or minor complication group” (CD Grade ≤ II, including no postoperative complications) and a “major complication group” (CD Grade ≥ III), and the impact of postoperative complications on survival outcomes were assessed. A subgroup analysis excluding macroscopic type 4 was also performed.&lt;/p&gt;
&lt;p&gt;Results&lt;/p&gt;&lt;p&gt;Postoperative complications occurred in 24 patients (39.3%), of which 8 (13.1%) experienced major complications. Patients in the major complication group had a significantly longer postoperative hospital stay, while other baseline characteristics were similar between groups. Kaplan–Meier analysis showed a trend toward poorer OS in the major complication group (P = 0.063), and recurrence-free survival (RFS) was significantly worse in this group (P = 0.004). Multivariate analysis showed that postoperative complications of CD grade ≥ III were independently associated with poorer OS (HR 2.51; 95% CI 1.01–6.24; P = 0.049). Subgroup analysis in patients without type 4 also showed significantly worse OS in the major complication group (P = 0.036).&lt;/p&gt;
&lt;p&gt;Conclusion&lt;/p&gt;&lt;p&gt;This study showed that postoperative complications were associated with poorer OS and RFS even in patients aged ≥80 years with gastric cancer. Future large-scale studies are needed to further clarify this association and optimize treatment strategies for this population.&lt;/p&gt;&lt;/div&gt;</dc:description>
          <dc:date>2026-09-29T17:29:42Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.1371/journal.pone.0359100.t003</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/_p_Multivariate_survival_analysis_p_/34026327</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
